Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Status: Recruiting
Phase: N/A
Diagnosis: Pediatric Neuroblastoma
NCT ID: NCT00904241 (View complete trial on ClinicalTrials.gov)
DFCI Protocol ID: 00-272

 

This laboratory study is looking at biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

 

Conducting Institutions:
Dana-Farber Cancer Institute, Children's Hospital Boston, Massachusetts General Hospital

Overall PI:
Suzanne Shusterman, MD, Dana-Farber Cancer Institute

Site-responsible Investigators:

Contacts:
Dana-Farber Cancer Institute: Childrens Hospital Pediatric Clinical Translation Investigation Program CTIP, ctip@partners.org
Massachusetts General Hospital: Cancer Trials Call Center, 877-789-6100

Eligibility Criteria

DISEASE CHARACTERISTICS: - Diagnosis of neuroblastoma or ganglioneuroblastoma within the past two weeks - No relapsed neuroblastoma at enrollment - No prior enrollment on a front-line COG therapeutic study (low-, intermediate-, or high-risk) PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - Not specified
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms